Analgesia for liver tumour ablation

Erector spinae plane block for radiofrequency ablation of hepatic focal lesions.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR201910524348185

Enrollment

Registered

2019-10-21

Start date

2019-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Anaesthesia

Interventions

erector spinae plane block

conscious sedation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Fifty patients aged 30-60 years both sex eligible for radio frequency ablation of hepatic focal lesions

Exclusion criteria

Exclusion criteria: patient's refusal expected difficult intubation neurological or psychiatric disorders Child-Paugh C classification local infection at injection site spine or chest wall deformity allergy to any of the study drugs opioid addiction uncooperative patients

Design outcomes

Primary

Measure	Time frame
Total fentanyl consumption during the procedure	—

Secondary

Measure	Time frame
pain will be assessed by non verbal pain score NVPS;time to first analgesic request;adverse effects e.g. nausea, vomiting, somnolence, hypotension,bradycardia,bradypnea,llocal anesthetic toxicity,or pneumothorax	—

Countries

Egypt

Contacts

Public ContactMohamed Lotfy

lecturer

Dr.Mohamed_lotfy@hotmail.com+201222444184

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026